Evidence map›Paper›PMID 30105916›Full record

ArticleAIDS research and human retroviruses2018

A Summary of the Third Annual HIV Microbiome Workshop.

Brett Williams, Charles Boucher, Frederic Bushman, Stacy Carrington-Lawrence, Ronald Collman, Satya Dandekar, Que Dang, Angela Malaspina, Roger Paredes, Cara Wilson and 4 more

Abstract readConference Proceedings
PubMed Full text at PMC Publisher
In one paragraph

Article in AIDS research and human retroviruses, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Brett Williams1 Division of Infectious Diseases, Rush University Medical Center , Chicago, Illinois.
Charles Boucher2 Department of Virosciences, Erasmus Medical Center, Erasmus University , Rotterdam, the Netherlands .
Frederic Bushman3 Department of Microbiology, Perelman School of Medicine, University of Pennsylvania , Philadelphia, Pennsylvania.
Stacy Carrington-Lawrence4 Office of AIDS Research, Division of Program Coordination, Planning, and Strategic Initiatives, Office of the Director, U.S. National Institutes of Health , U.S. Department of Health and Human Services, Bethesda, Maryland.
Ronald Collman5 Department of Medicine, Perelman School of Medicine, University of Pennsylvania , Philadelphia, Pennsylvania.
Satya Dandekar6 Department of Medical Microbiology and Immunology, University of California , Davis, California.
Que Dang7 Vaccine Research Program, Division of AIDS, National Institute of Allergy and Infectious Diseases , Bethesda, Maryland.
Angela Malaspina7 Vaccine Research Program, Division of AIDS, National Institute of Allergy and Infectious Diseases , Bethesda, Maryland.
Roger Paredes8 Institut de Recerca de la SIDA IrsiCaixa i Unitat VIH, Universitat Autònoma de Barcelona, Universitat de Vic , Catalonia, Spain .
Cara Wilson9 Department of Medicine, University of Colorado at Denver , Denver, Colorado.
Piotr Nowak10 Department of Medicine, Unit of Infectious Diseases, Karolinska University Hospital , Karolinska Institutet, Stockholm, Sweden .
Nichole Klatt11 Department of Pharmaceutics, Washington National Primate Research Center, University of Washington , Seattle, Washington.
Laurel Lagenaur12 Osel, Inc. , Mountain View, California.
Alan Landay13 Department of Immunology/Microbiology, Rush University Medical Center , Chicago, Illinois.

Funding

Virus & Reservoirs CoreP30AI045008 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI ROBERT GROSS · 1999 to 2026
$78.6M
HIV: gp120, Chemokine Receptors &Macrophage ActivationR01MH061139 · NIMH · UNIVERSITY OF PENNSYLVANIA · PI COLLMAN, RONALD G · 1999 to 2015
$5.2M
Epigenetic HIV Silencing in MacrophagesR61AI133696 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI COLLMAN, RONALD G, LIEBERMAN, PAUL M. · 2017 to 2019
$2.6M
The Lung DNA Virome in Health and DiseaseR33HL137063 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI BUSHMAN, FREDERIC D, COLLMAN, RONALD G · 2019 to 2021
$2.3M
NHLBI NIH HHS R33 HL137063NIAID NIH HHS P30 AI045008NIAID NIH HHS R61 AI133696NIMH NIH HHS R01 MH061139
6 · The paper itself

Abstract

Our microbial cotravelers have increasingly apparent roles in both maintaining health and causing disease in several organ systems. Investigators gather annually at the National Institutes of Health to present new discoveries regarding the role of the microbiome in human health and a special focus on persons living with HIV. Here, we summarize the discussions from the third annual Virology Education workshop on the microbiome in HIV, which took place in October of 2017.

Indexed as

AIDS VaccinesAnimalsBacterial TranslocationBrainCardiovascular DiseasesDietDysbiosisHIV InfectionsHost-Pathogen InteractionsHumansIntestinal MucosaMicrobiotaAIDS VaccinescomorbiditiesHIVimmune activationmicrobial translocationmicrobiomemucosal immunology

Identifiers

PMID30105916
PMCPMC6422011

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.